Atrial Fibrillation

"Atrial Fibrillation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Descriptor ID	D001281
MeSH Number(s)	C14.280.067.198 C23.550.073.198
Concept/Terms	Atrial Fibrillation Atrial Fibrillation Atrial Fibrillations Fibrillation, Atrial Fibrillations, Atrial Auricular Fibrillation Auricular Fibrillations Fibrillation, Auricular Fibrillations, Auricular Persistent Atrial Fibrillation Persistent Atrial Fibrillation Atrial Fibrillation, Persistent Atrial Fibrillations, Persistent Fibrillation, Persistent Atrial Fibrillations, Persistent Atrial Persistent Atrial Fibrillations Familial Atrial Fibrillation Familial Atrial Fibrillation Atrial Fibrillation, Familial Atrial Fibrillations, Familial Familial Atrial Fibrillations Fibrillation, Familial Atrial Fibrillations, Familial Atrial Paroxysmal Atrial Fibrillation Paroxysmal Atrial Fibrillation Atrial Fibrillation, Paroxysmal Atrial Fibrillations, Paroxysmal Fibrillation, Paroxysmal Atrial Fibrillations, Paroxysmal Atrial Paroxysmal Atrial Fibrillations

Below are MeSH descriptors whose meaning is more general than "Atrial Fibrillation".

Diseases [C]
Cardiovascular Diseases [C14]
Heart Diseases [C14.280]
Arrhythmias, Cardiac [C14.280.067]
Atrial Fibrillation [C14.280.067.198]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Arrhythmias, Cardiac [C23.550.073]
Atrial Fibrillation [C23.550.073.198]

Below are MeSH descriptors whose meaning is related to "Atrial Fibrillation".

Below are MeSH descriptors whose meaning is more specific than "Atrial Fibrillation".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Atrial Fibrillation" by people in this website by year, and whether "Atrial Fibrillation" was a major or minor topic of these publications.

Bar chart showing 93 publications over 20 distinct years, with a maximum of 15 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
1999	2	0	2
2002	2	0	2
2003	0	1	1
2005	1	0	1
2007	1	0	1
2009	1	0	1
2011	1	1	2
2012	2	0	2
2013	3	0	3
2014	2	0	2
2015	3	0	3
2016	8	1	9
2017	12	0	12
2018	7	0	7
2019	9	1	10
2020	14	1	15
2021	8	1	9
2022	3	0	3
2023	7	0	7

Below are the most recent publications written about "Atrial Fibrillation" by people in Profiles.

Inoue K, Guo R, Lee ML, Ebrahimi R, Neverova NV, Currier JW, Bashir MT, Leung AM. Iodine-Induced Hyperthyroidism and Long-term Risks of Incident Atrial Fibrillation and Flutter. J Clin Endocrinol Metab. 2023 09 18; 108(10):e956-e962.

View in: PubMed
Segan L, Chieng D, Sugumar H, Voskoboinik A, Ling LH, Costello B, Azzopardi S, Nderitu Z, Parameswaran R, Amerena J, McLellan AJ, Lee G, Morton J, Joseph S, Wong M, Taylor A, Kalman JM, Kistler PM, Prabhu S. The impact of age on ablation outcomes in AF-mediated cardiomyopathy. J Cardiovasc Electrophysiol. 2023 10; 34(10):2065-2075.

View in: PubMed
Jeon WK, Lee SR, Han KD, Choi EK, Oh S, Lip GYH. Association between the accumulation of elevated serum ?-glutamyltransferase level and risk of atrial fibrillation: a nationwide cohort study. Sci Rep. 2023 08 23; 13(1):13771.

View in: PubMed
Papapostolou S, Kearns J, Costello BT, O'Brien J, Rudman M, Thompson MC, Cloud G, Stub D, Taylor AJ. Assessing atrial myopathy with cardiac magnetic resonance imaging in embolic stroke of undetermined source. Int J Cardiol. 2023 10 15; 389:131215.

View in: PubMed
Han KD, Hwang Y, Park SH. Blood pressure status affects atrial fibrillation in diabetic end-stage renal disease. PLoS One. 2023; 18(4):e0283875.

View in: PubMed
Chieng D, Sugumar H, Segan L, Tan C, Vizi D, Nanayakkara S, Al-Kaisey A, Hawson J, Prabhu S, Voskoboinik A, Finch S, Morton JB, Lee G, Mariani J, La Gerche A, Taylor AJ, Howden E, Kistler PM, Kalman JM, Kaye DM, Ling LH. Atrial Fibrillation Ablation for Heart?Failure With Preserved Ejection?Fraction: A Randomized Controlled Trial. JACC Heart Fail. 2023 06; 11(6):646-658.

View in: PubMed
Lee HJ, Kim HK, Kim BS, Han KD, Park CS, Rhee TM, Park JB, Lee H, Kim YJ. Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment. Sci Rep. 2023 02 04; 13(1):2060.

View in: PubMed
Guo JS, He M, Gabriel N, Magnani JW, Kimmel SE, Gellad WF, Hernandez I. Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation. J Manag Care Spec Pharm. 2022 Dec; 28(12):1400-1409.

View in: PubMed
Choi YJ, Kim B, Rhee TM, Lee HJ, Lee H, Park JB, Lee SP, Han KD, Kim YJ, Kim HK. Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation. Sci Rep. 2022 09 22; 12(1):15785.

View in: PubMed
Park J, Jung JH, Choi EK, Lee SW, Kwon S, Lee SR, Kang J, Han KD, Park KW, Oh S, Lip GYH. Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. PLoS One. 2022; 17(2):e0264538.

View in: PubMed

People

Explore

Similar Concepts

Top Journals